amlotinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for amlotinib, covering 2021-08-03 to 2021-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma [Phase 2]